Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: A 1-year randomized trial

Contraception

Volumn 71, Issue 3, 2005, Pages 176-182

  Oddsson, Kristjan ^a   Leifels Fischer, Beate ^b   De Melo, Nilson Roberto ^c   Wiel Masson, Dominique ^d   Benedetto, Chiara ^e   Verhoeven, Carole H J ^f   Dieben, Thom O M ^f  

^a Idungården Legesenter   (Norway)

^b Frauenarztpraxis   (Germany)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d University of Turin ^*  (France)

^e UNIVERSITY OF TURIN   (Italy)

^f NV ORGANON   (Netherlands)

Author keywords

Compliance; Contraceptive; Efficacy; NuvaRing; Pill; Tolerability

Indexed keywords

ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL PAIN; ACNE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; LEG PAIN; LEUKORRHEA; LIBIDO DISORDER; MASTALGIA; NAUSEA; ORAL CONTRACEPTION; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PREGNANCY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINUSITIS; URINARY TRACT INFECTION; VAGINA DISEASE; VAGINA RING; VAGINITIS; VEIN THROMBOSIS; WEIGHT GAIN;

EID: 13844265878     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2004.09.001     Document Type: Article

References (12)

1. C.J. Timmer, and T.M. Mulders Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring Clin. Pharmacokinet. 39 2000 233 242
2. R.T. Burkman Oral contraceptives: current status Clin. Obstet. Gynecol. 44 2001 62 72
3. M. Rosenberg, and M.S. Waugh Causes and consequences of oral contraceptive noncompliance Am. J. Obstet. Gynecol. 180 1999 S276 S279
4. A. Novak, C. de la Loge, L. Abetz, and E.A. van der Meulen The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability Contraception 67 2003 187 194
5. T.O.M. Dieben, F.J. Roumen, and D. Apter Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring Obstet. Gynecol. 100 2002 585 593
6. F.J. Roumen, D. Apter, T.M. Mulders, and T.O. Dieben Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol Hum. Reprod. 16 2001 469 475
7. R.I. Bjarnadóttir, M. Tuppurainen, and S.R. Killick Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol Am. J. Obstet. Gynecol. 186 2002 389 395
8. J.R. Newton Classification and comparison of oral contraceptives containing new generation progestogens Hum. Reprod. Update 1 1995 231 263
9. J. Endikrat, M. Cronin, and C. Gerlinger Double-blind, multicentre comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 μg ethinyl estradiol and 75 μg gestodene Contraception 64 2001 99 105
10. J. Endikrat, M. Cronin, and C. Gerlinger Open, multicentre comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel Contraception 64 2001 201 207
11. K.D. LaGuardia, G. Shangold, and A. Fisher Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol Contraception 67 2003 431 437
12. M.R. Comparato, J.A. Yabur, and M. Bajares Contraceptive efficacy and acceptability of a monophasic oral contraceptive containing 30 μg ethinyl estradiol and 150 μg desogestrel in Latin-American women Adv. Contracep. 14 1998 15 26